Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma

Overview of attention for article published in BMC Cancer, July 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,560 followers.

RT @PestanaRC: Regarding novel therapies, trabectedin has demonstrated promising results In a subanalysis of a Phase 2 trial, among 6 pts,…

02 Feb 2022

Reply Repost Favourite

Regarding novel therapies, trabectedin has demonstrated promising results In a subanalysis of a Phase 2 trial, among 6 pts, all achieved disease control and 6-months PFS was 100% https://t.co/hXHwjjsEmi

17 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.